Skip to main content

ProShare Advisors LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1357955 BETHESDA, MD

Position in ESPR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
160,493
+251.8% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $31,211,469 across 27 Drug Manufacturers - Specialty & Generic names. ESPR ranks #27 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 160,493
2026-03-31 45,615
2025-12-31 53,315
2025-09-30 41,327
2025-06-30 48,347
2025-03-31 49,795
2024-12-31 62,549
2024-09-30 35,706
2023-03-31 13,989
2022-12-31 15,583
2022-09-30 12,940
2022-06-30 11,992
2022-03-31 17,332
2021-12-31 10,015
2021-06-30 11,875
2021-03-31 10,783
2020-12-31 10,035
2020-09-30 7,655
2020-06-30 7,932